Mark T. Gleason
Präsident bei Cortland Communications LLC
Ursprung des Netzwerks ersten Grades von Mark T. Gleason
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
American Housing Income Trust, Inc.
 American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ.
6
| Extinct | Real Estate Investment Trusts | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark T. Gleason
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
American Realty Partners LLC
 American Realty Partners LLC HomebuildingConsumer Durables American Realty Partners LLC engages in the acquisition, renovation, leasing, and management of single-family residential properties. It purchases real estate making cosmetic change, repair, and other enhancement of the properties. The company is headquartered in Phoenix, AZ. | Homebuilding | Chairman | |
| Northern Arizona University | College/University | Undergraduate Degree | |
| SC HLDG | Investment Managers | Chief Executive Officer | |
| EVOLUTION TECHNOLOGY RESOURCES INC. | Packaged Software | Chief Executive Officer | |
| CORIX BIOSCIENCE, INC. | Pharmaceuticals: Other | Director/Board Member | |
QMIS TBS Capital Group Corp.
 QMIS TBS Capital Group Corp. Financial ConglomeratesFinance QMIS TBS Capital Group Corp. is a development stage company. The company plans to engage in the business of providing financial services. QMIS TBS Capital Group was founded on November 21, 2019 and is headquartered in Flushing, NY. | Financial Conglomerates | Director of Finance/CFO | |
Cellebration Life Sciences, Inc.
 Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation. | Biotechnology | Founder |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
Sektoral
| Finance | 3 |
| Health Technology | 3 |
| Consumer Durables | 2 |
| Consumer Services | 2 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 6 |
| Chief Executive Officer | 6 |
| Director of Finance/CFO | 4 |
| President | 3 |
| Chairman | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Mark T. Gleason
- Unternehmensverbindungen
